Ban Abortion by Mail Act
To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
This bill aims to change how mifepristone, a medication used in certain medical procedures, can be prescribed. It would require that a healthcare provider certified through a Risk Evaluation and Mitigation Strategy (REMS) program can only prescribe mifepristone if they have both an in-person visit with the patient and a medical license in the state where the patient lives. This law would affect healthcare providers and patients who need this medication.
The bill was introduced on June 24, 2026, and is currently being reviewed by the House Committee on Energy and Commerce. This means it is in the early stages of the legislative process, and there are many steps before it could become law. It was first introduced in the House and referred to a specific committee for further review.
Recent actions include the bill being introduced on June 24, 2026, and then immediately referred to the House Committee on Energy and Commerce for additional review. Future steps will involve committee discussions, possible amendments, and votes before it can move to the next stages of the legislative process.
